Literature DB >> 21752155

Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

M Camilleri1, P Carlson, S McKinzie, M Zucchelli, M D'Amato, I Busciglio, D Burton, A R Zinsmeister.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) coexist in some patients. We observed an association between Crohn's disease (CD) candidate gene TNFSF15 and IBS symptom phenotype. Three genes (TLR9, IL6, and CDH1) have been associated with postinfectious (PI)-IBS. Our aim was to preliminarily assess association between 30 susceptibility loci for CD, three genes associated with PI-IBS, and PARM1, with colonic transit in lower functional gastrointestinal disorders (FGID).
METHODS: A cohort of 665 persons was assembled in previous studies. TaqMan assay was used for all single nucleotide polymorphisms (SNPs) associated with the loci of interest. Data were analyzed for univariate associations with symptoms phenotype and colonic transit (nominal P values, uncorrected) using dominant and co-dominant genetic models. KEY
RESULTS: Carriers of the rs5743836 risk allele had increased odds for IBS-D (vs control, P = 0.02, uncorrected). Among the CD risk loci, rs7927894 (P = 0.007), rs7746082 (P=0.011), rs2872507 (P = 0.014), together with rs5743836 (P = 0.010) were univariately associated with colonic transit at 24 or 48 h. Specific tests for genetic interactions between loci revealed potential association of genes that influence neural, barrier, or mast cell function with colonic transit. CONCLUSIONS & INFERENCES: Genetic variations that may influence local mucosal immune functions are univariately associated with altered colonic transit in lower FGID.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21752155      PMCID: PMC3173581          DOI: 10.1111/j.1365-2982.2011.01749.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  45 in total

Review 1.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

2.  Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Marroon Thabane; Alexandre Belisle; Geneviève Geneau; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins; Denis Franchimont; John K Marshall
Journal:  Gastroenterology       Date:  2010-01-04       Impact factor: 22.682

Review 3.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

4.  Orm family proteins mediate sphingolipid homeostasis.

Authors:  David K Breslow; Sean R Collins; Bernd Bodenmiller; Ruedi Aebersold; Kai Simons; Andrej Shevchenko; Christer S Ejsing; Jonathan S Weissman
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

5.  Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

Authors:  N Manabe; B S Wong; M Camilleri; D Burton; S McKinzie; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2009-12-21       Impact factor: 3.598

6.  Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions.

Authors:  A Deiteren; M Camilleri; A E Bharucha; D Burton; S McKinzie; A S Rao; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2009-12-18       Impact factor: 3.598

7.  Genome-wide association identifies multiple ulcerative colitis susceptibility loci.

Authors:  Dermot P B McGovern; Agnès Gardet; Leif Törkvist; Philippe Goyette; Jonah Essers; Kent D Taylor; Benjamin M Neale; Rick T H Ong; Caroline Lagacé; Chun Li; Todd Green; Christine R Stevens; Claudine Beauchamp; Phillip R Fleshner; Marie Carlson; Mauro D'Amato; Jonas Halfvarson; Martin L Hibberd; Mikael Lördal; Leonid Padyukov; Angelo Andriulli; Elisabetta Colombo; Anna Latiano; Orazio Palmieri; Edmond-Jean Bernard; Colette Deslandres; Daan W Hommes; Dirk J de Jong; Pieter C Stokkers; Rinse K Weersma; Yashoda Sharma; Mark S Silverberg; Judy H Cho; Jing Wu; Kathryn Roeder; Steven R Brant; L Phillip Schumm; Richard H Duerr; Marla C Dubinsky; Nicole L Glazer; Talin Haritunians; Andy Ippoliti; Gil Y Melmed; David S Siscovick; Eric A Vasiliauskas; Stephan R Targan; Vito Annese; Cisca Wijmenga; Sven Pettersson; Jerome I Rotter; Ramnik J Xavier; Mark J Daly; John D Rioux; Mark Seielstad
Journal:  Nat Genet       Date:  2010-03-14       Impact factor: 38.330

8.  Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.

Authors:  Darab Ghadimi; Michael de Vrese; Knut J Heller; Juergen Schrezenmeir
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

Review 9.  The putative role of the intestinal microbiota in the irritable bowel syndrome.

Authors:  S M Collins; E Denou; E F Verdu; P Bercik
Journal:  Dig Liver Dis       Date:  2009-09-08       Impact factor: 4.088

10.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.

Authors:  Jeffrey C Barrett; James C Lee; Charles W Lees; Natalie J Prescott; Carl A Anderson; Anne Phillips; Emma Wesley; Kirstie Parnell; Hu Zhang; Hazel Drummond; Elaine R Nimmo; Dunecan Massey; Kasia Blaszczyk; Timothy Elliott; Lynn Cotterill; Helen Dallal; Alan J Lobo; Craig Mowat; Jeremy D Sanderson; Derek P Jewell; William G Newman; Cathryn Edwards; Tariq Ahmad; John C Mansfield; Jack Satsangi; Miles Parkes; Christopher G Mathew; Peter Donnelly; Leena Peltonen; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Mark I McCarthy; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Nilesh Samani; Richard C Trembath; Anath C Viswanathan; Nicholas Wood; Chris C A Spencer; Jeffrey C Barrett; Céline Bellenguez; Daniel Davison; Colin Freeman; Amy Strange; Peter Donnelly; Cordelia Langford; Sarah E Hunt; Sarah Edkins; Rhian Gwilliam; Hannah Blackburn; Suzannah J Bumpstead; Serge Dronov; Matthew Gillman; Emma Gray; Naomi Hammond; Alagurevathi Jayakumar; Owen T McCann; Jennifer Liddle; Marc L Perez; Simon C Potter; Radhi Ravindrarajah; Michelle Ricketts; Matthew Waller; Paul Weston; Sara Widaa; Pamela Whittaker; Panos Deloukas; Leena Peltonen; Christopher G Mathew; Jenefer M Blackwell; Matthew A Brown; Aiden Corvin; Mark I McCarthy; Chris C A Spencer; Antony P Attwood; Jonathan Stephens; Jennifer Sambrook; Willem H Ouwehand; Wendy L McArdle; Susan M Ring; David P Strachan
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

View more
  14 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Orexins stimulate the 'appetite' of the gut.

Authors:  Shinsuke Nakayama
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

3.  Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility.

Authors:  Bindu Chandrasekharan; Sabrina Jeppsson; Stefan Pienkowski; Denise D Belsham; Shanthi V Sitaraman; Didier Merlin; Efi Kokkotou; Asma Nusrat; Malu G Tansey; Shanthi Srinivasan
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

Review 4.  Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Authors:  Yehuda Ringel; Nitsan Maharshak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

Review 5.  Brain-gut axis: from basic understanding to treatment of IBS and related disorders.

Authors:  Michael Camilleri; Carlo Di Lorenzo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

Review 6.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 7.  Cannabinoids and GI Disorders: Endogenous and Exogenous.

Authors:  Zachary Wilmer Reichenbach; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 8.  Genetics of human gastrointestinal sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2013-04-17       Impact factor: 3.598

9.  Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.

Authors:  Michael Camilleri; Andrea Shin; Irene Busciglio; Paula Carlson; Andres Acosta; Adil E Bharucha; Duane Burton; Jesse Lamsam; Alan Lueke; Leslie J Donato; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-10       Impact factor: 4.052

Review 10.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.